MET - NYSE
MetLife, Inc.
$80.96
-1.1%MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
At a Glance
Live SnapshotMetLife, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Strong gross margins indicate healthy pricing and efficient production or service delivery.
Operating Margin
Acceptable margins but limited operational leverage. Operating expense control is important.
Net Profit Margin
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
MetLife, Inc. Income Statement
MET • NYSE
| MetLife, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
77.1B | 69.9B | 67.7B | 68B | 63.4B | 67.9B | 69.6B | 67.9B | 62.3B | 60.5B | 61.3B | 73.3B | 68.2B | 66.3B | 70.2B | 52.2B | 41.1B | 51B | 47.2B | 48.3B | |
GROSS PROFIT | ||||||||||||||||||||
(49.1B) | (50.9B) | (50.4B) | (49B) | (46.5B) | (52.4B) | (53.4B) | (52B) | (48.8B) | (46.6B) | (45.2B) | (51.6B) | (50.7B) | (50.5B) | (46.4B) | (37.7B) | (33.2B) | (32.2B) | (33.4B) | (35.4B) | |
28B | 19B | 17.3B | 18.9B | 16.8B | 15.5B | 16.2B | 15.9B | 13.5B | 14B | 16.2B | 21.8B | 17.5B | 15.8B | 23.8B | 14.5B | 7.9B | 18.8B | 13.8B | 12.8B | |
OPERATING INCOME | ||||||||||||||||||||
(23.4B) | (13.4B) | (15.1B) | (12.6B) | (8.3B) | (8.5B) | (9.4B) | (9.6B) | (9.9B) | (9.7B) | (10.5B) | (12.9B) | (13.4B) | (14.3B) | (14.6B) | (10.8B) | (12.2B) | (13.7B) | (8B) | (8.7B) | |
(0.0) | (6B) | (6.2B) | (5.9B) | (5.8B) | (5.8B) | (6.6B) | (6.5B) | (6.7B) | (6.9B) | (7.3B) | (7.2B) | (7.4B) | (8.1B) | (7.8B) | (5.4B) | (8.6B) | (7.2B) | (7.1B) | (3.4B) | |
4.7B | 5.6B | 2.2B | 6.4B | 8.5B | 6.9B | 6.8B | 6.3B | 3.5B | 4.3B | 5.7B | 8.8B | 4.1B | 1.4B | 9.2B | 3.7B | -4.3B | 5.1B | 5.8B | 4.2B | |
PRE-TAX INCOME | ||||||||||||||||||||
(1.1B) | (1B) | (1B) | (938M) | (920M) | (913M) | (955M) | (1.1B) | (1.1B) | (1.2B) | (1.2B) | (1.2B) | (1.3B) | (1.4B) | (1.7B) | (1.7B) | (876M) | (720M) | (600M) | (900M) | |
-1.1B | -1B | -1B | -938M | -920M | -913M | -955M | -1.1B | -1.1B | -1.2B | -1.2B | -1.2B | -1.3B | -1.4B | -1.7B | -1.7B | -876M | -720M | -600M | -900M | |
(23.4B) | (7.4B) | (9B) | (6.7B) | (2.6B) | (2.8B) | (2.8B) | (3.1B) | (3.2B) | (2.8B) | (3.2B) | (5.8B) | (6B) | (6.3B) | (6.9B) | (5.4B) | (3.6B) | (6.5B) | (910M) | (5.2B) | |
4.7B | 5.6B | 2.2B | 6.4B | 8.5B | 6.9B | 6.8B | 6.3B | 3.5B | 4.3B | 5.7B | 8.8B | 4.1B | 1.4B | 9.2B | 3.7B | -4.3B | 5.1B | 5.8B | 4.2B | |
NET INCOME | ||||||||||||||||||||
(1.3B) | (1.2B) | (560M) | (1.1B) | (1.6B) | (1.5B) | (886M) | (1.2B) | -1.5B | (693M) | (1.6B) | (2.5B) | (661M) | (128M) | (2.8B) | (1.1B) | -2B | (1.6B) | (1.7B) | (1.1B) | |
3.4B | 4.4B | 1.6B | 5.3B | 6.9B | 5.4B | 5.9B | 5.1B | 4B | 850M | 5.4B | 6.3B | 3.4B | 1.3B | 6.4B | 2.7B | -2.2B | 3.2B | 4.3B | 6.3B |
SEC Filings
MET - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 15, 2026 | May 15, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 29, 2026 | June 16, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 07, 2026 | April 07, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 24, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 24, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 19, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 17, 2026 | February 17, 2026 | 2026 |
Related Guides
Continue your MET research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.